Ascend Wellness Holdings (AAWH) EBT Margin Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | -243.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -243.00 |
| Mar 31, 2026 | -861.00 |
| Dec 31, 2025 | -2,252.00 |
| Sep 30, 2025 | 219.00 |
| Jun 30, 2025 | -304.00 |
| Mar 31, 2025 | -246.00 |
| Dec 31, 2024 | 84.00 |
| Sep 30, 2024 | -986.00 |
| Jun 30, 2024 | -1,137.00 |
| Mar 31, 2024 | 344.00 |
| Dec 31, 2023 | -248.00 |
| Sep 30, 2023 | 191.00 |
| Jun 30, 2023 | 1,448.00 |
| Mar 31, 2023 | 1,693.00 |
| Dec 31, 2022 | 634.00 |
| Sep 30, 2022 | -435.00 |
| Jun 30, 2022 | 2,952.00 |
| Mar 31, 2022 | 3,501.00 |
| Dec 31, 2021 | -817.00 |
| Sep 30, 2021 | -252.00 |